Cargando…

Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51

BACKGROUND/AIMS: The clinical manifestations of Behcet disease (BD) have been reported to differ according to country, region, and race. Gender, onset age, and human leukocyte antigen (HLA)-B51 have also been known as the factors that influence the clinical features of BD. The aim of this study is t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Hee Jung, Seo, Mi Ryoung, Choi, Hyo Jin, Baek, Han Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129630/
https://www.ncbi.nlm.nih.gov/pubmed/28073242
http://dx.doi.org/10.3904/kjim.2016.202
_version_ 1783353814447816704
author Ryu, Hee Jung
Seo, Mi Ryoung
Choi, Hyo Jin
Baek, Han Joo
author_facet Ryu, Hee Jung
Seo, Mi Ryoung
Choi, Hyo Jin
Baek, Han Joo
author_sort Ryu, Hee Jung
collection PubMed
description BACKGROUND/AIMS: The clinical manifestations of Behcet disease (BD) have been reported to differ according to country, region, and race. Gender, onset age, and human leukocyte antigen (HLA)-B51 have also been known as the factors that influence the clinical features of BD. The aim of this study is to investigate the clinical phenotypes of Korean patients who visited the rheumatology clinic with BD with respect to gender, onset age, and HLA-B51. METHODS: Total 193 Korean patients (129 females and 64 males) fulfilling the international criteria for BD were retrospectively assessed. RESULTS: The mean age at disease onset and disease duration of the BD patients were 32.2 ± 11.1 and 14.2 ± 9.3 years, retrospectively. Females suffered more frequently from genital ulcers (90.7% vs. 75.0%, p < 0.01), peripheral arthritis (67.4% vs. 43.8%, p < 0.01), and inf lammatory low back pain (38.8% vs. 23.4%, p = 0.03) than males, while skin involvement was more frequent in males than in females (90.6% vs. 75.2%, p = 0.01). The patients with late onset of BD (> 40 years) suffered from neurologic involvement (15.9% vs. 4.2%, p = 0.007) more frequently than those with early onset of BD. The patients with HLA-B51 showed earlier onset of disease than without HLA-B51 (28.3 ± 11.4 years vs. 33.8±11.6 years, p = 0.02) and the neurologic and gastrointestinal involvements were more frequent in the patients without HLA-B51 than with HLA-B51 (17.2% vs. 2.5%, p = 0.02 and 20.7% vs. 2.5%, p = 0.01, respectively). CONCLUSIONS: The clinical phenotypes in Korean patients with BD may be influenced by gender, onset age and HLA-B51.
format Online
Article
Text
id pubmed-6129630
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Association of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-61296302018-09-11 Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51 Ryu, Hee Jung Seo, Mi Ryoung Choi, Hyo Jin Baek, Han Joo Korean J Intern Med Original Article BACKGROUND/AIMS: The clinical manifestations of Behcet disease (BD) have been reported to differ according to country, region, and race. Gender, onset age, and human leukocyte antigen (HLA)-B51 have also been known as the factors that influence the clinical features of BD. The aim of this study is to investigate the clinical phenotypes of Korean patients who visited the rheumatology clinic with BD with respect to gender, onset age, and HLA-B51. METHODS: Total 193 Korean patients (129 females and 64 males) fulfilling the international criteria for BD were retrospectively assessed. RESULTS: The mean age at disease onset and disease duration of the BD patients were 32.2 ± 11.1 and 14.2 ± 9.3 years, retrospectively. Females suffered more frequently from genital ulcers (90.7% vs. 75.0%, p < 0.01), peripheral arthritis (67.4% vs. 43.8%, p < 0.01), and inf lammatory low back pain (38.8% vs. 23.4%, p = 0.03) than males, while skin involvement was more frequent in males than in females (90.6% vs. 75.2%, p = 0.01). The patients with late onset of BD (> 40 years) suffered from neurologic involvement (15.9% vs. 4.2%, p = 0.007) more frequently than those with early onset of BD. The patients with HLA-B51 showed earlier onset of disease than without HLA-B51 (28.3 ± 11.4 years vs. 33.8±11.6 years, p = 0.02) and the neurologic and gastrointestinal involvements were more frequent in the patients without HLA-B51 than with HLA-B51 (17.2% vs. 2.5%, p = 0.02 and 20.7% vs. 2.5%, p = 0.01, respectively). CONCLUSIONS: The clinical phenotypes in Korean patients with BD may be influenced by gender, onset age and HLA-B51. The Korean Association of Internal Medicine 2018-09 2017-01-12 /pmc/articles/PMC6129630/ /pubmed/28073242 http://dx.doi.org/10.3904/kjim.2016.202 Text en Copyright © 2017 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ryu, Hee Jung
Seo, Mi Ryoung
Choi, Hyo Jin
Baek, Han Joo
Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51
title Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51
title_full Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51
title_fullStr Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51
title_full_unstemmed Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51
title_short Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51
title_sort clinical phenotypes of korean patients with behcet disease according to gender, age at onset, and hla-b51
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129630/
https://www.ncbi.nlm.nih.gov/pubmed/28073242
http://dx.doi.org/10.3904/kjim.2016.202
work_keys_str_mv AT ryuheejung clinicalphenotypesofkoreanpatientswithbehcetdiseaseaccordingtogenderageatonsetandhlab51
AT seomiryoung clinicalphenotypesofkoreanpatientswithbehcetdiseaseaccordingtogenderageatonsetandhlab51
AT choihyojin clinicalphenotypesofkoreanpatientswithbehcetdiseaseaccordingtogenderageatonsetandhlab51
AT baekhanjoo clinicalphenotypesofkoreanpatientswithbehcetdiseaseaccordingtogenderageatonsetandhlab51